389MO Risk of bowel obstruction in patients undergoing neoadjuvant chemotherapy for high-risk colon cancer: A nested case-control matched analysis of an international, multi-centre, randomised controlled trial (FOxTROT)

J Glasbey,J Seligmann,D.G Morton,The Foxtrot Collaborating Group The Foxtrot Collaborating Group

doi:10.1016/j.annonc.2021.08.911

389MO Risk of bowel obstruction in patients undergoing neoadjuvant chemotherapy for high-risk colon cancer: A nested case-control matched analysis of an international, multi-centre, randomised controlled trial (FOxTROT)

J Glasbey, J Seligmann + Show 2 more

Open Access

https://doi.org/10.1016/j.annonc.2021.08.911

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Sep 1, 2021
Citations: 1	License type: publisher-specific-oa

Affiliation: University of Birmingham, Leeds Teaching Hospitals NHS Trust

#Bowel Obstruction In Patients #Chemotherapy For Colon Cancer + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

389MO Risk of bowel obstruction in patients undergoing neoadjuvant chemotherapy for high-risk colon cancer: A nested case-control matched analysis of an international, multi-centre, randomised controlled trial (FOxTROT)

Full Text